Dr. Julie Gerberding is chief patient officer and executive vice president at Merck. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.L. Gerberding and B.F. Haynes. Vaccine Innovations — Past and Future. N Engl J Med 2021;